Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer.

Grosselin K, Durand A, Marsolier J, Poitou A, Marangoni E, Nemati F, Dahmani A, Lameiras S, Reyal F, Frenoy O, Pousse Y, Reichen M, Woolfe A, Brenan C, Griffiths AD, Vallot C, Gérard A.

Nat Genet. 2019 Jun;51(6):1060-1066. doi: 10.1038/s41588-019-0424-9. Epub 2019 May 31.

PMID:
31152164
2.

Modeling the Influence of Age on Neurological Outcome and Quality of Life One Year after Traumatic Brain Injury: A Prospective Multi-Center Cohort Study.

Bouzat P, Ageron FX, Thomas M, Vallot C, Hautefeuille S, Schilte C, Payen JF.

J Neurotrauma. 2019 Sep 1;36(17):2506-2512. doi: 10.1089/neu.2019.6432. Epub 2019 May 23.

PMID:
30990114
3.

Parallel derivation of isogenic human primed and naive induced pluripotent stem cells.

Kilens S, Meistermann D, Moreno D, Chariau C, Gaignerie A, Reignier A, Lelièvre Y, Casanova M, Vallot C, Nedellec S, Flippe L, Firmin J, Song J, Charpentier E, Lammers J, Donnart A, Marec N, Deb W, Bihouée A, Le Caignec C, Pecqueur C, Redon R, Barrière P, Bourdon J, Pasque V, Soumillon M, Mikkelsen TS, Rougeulle C, Fréour T, David L; Milieu Intérieur Consortium.

Nat Commun. 2018 Jan 24;9(1):360. doi: 10.1038/s41467-017-02107-w.

4.

Single-cell Visualization of Chromosome Transcriptional Territories by RNA-paint.

Vallot C, Rougeulle C.

Bio Protoc. 2016 Sep 5;6(17). pii: e1914. doi: 10.21769/BioProtoc.1914.

5.

The Smurf transition: new insights on ageing from end-of-life studies in animal models.

Rera M, Vallot C, Lefrançois C.

Curr Opin Oncol. 2018 Jan;30(1):38-44. doi: 10.1097/CCO.0000000000000419. Review.

PMID:
29064844
6.

Patient eligibility for thrombectomy after acute stroke: Northern French Alps database analysis.

Papassin J, Favre-Wiki IM, Atroun T, Tahon F, Boubagra K, Rodier G, Bing F, Marcel S, Vallot C, Belle L, Hommel M, Detante O.

Rev Neurol (Paris). 2017 Apr;173(4):216-221. doi: 10.1016/j.neurol.2017.03.010. Epub 2017 Apr 1.

PMID:
28377089
7.

XACT Noncoding RNA Competes with XIST in the Control of X Chromosome Activity during Human Early Development.

Vallot C, Patrat C, Collier AJ, Huret C, Casanova M, Liyakat Ali TM, Tosolini M, Frydman N, Heard E, Rugg-Gunn PJ, Rougeulle C.

Cell Stem Cell. 2017 Jan 5;20(1):102-111. doi: 10.1016/j.stem.2016.10.014. Epub 2016 Dec 15.

8.

Ordered chromatin changes and human X chromosome reactivation by cell fusion-mediated pluripotent reprogramming.

Cantone I, Bagci H, Dormann D, Dharmalingam G, Nesterova T, Brockdorff N, Rougeulle C, Vallot C, Heard E, Chaligne R, Merkenschlager M, Fisher AG.

Nat Commun. 2016 Aug 10;7:12354. doi: 10.1038/ncomms12354.

9.

Establishment of X chromosome inactivation and epigenomic features of the inactive X depend on cellular contexts.

Vallot C, Ouimette JF, Rougeulle C.

Bioessays. 2016 Sep;38(9):869-80. doi: 10.1002/bies.201600121. Epub 2016 Jul 8. Review.

PMID:
27389958
10.

Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency.

Chen H, Aksoy I, Gonnot F, Osteil P, Aubry M, Hamela C, Rognard C, Hochard A, Voisin S, Fontaine E, Mure M, Afanassieff M, Cleroux E, Guibert S, Chen J, Vallot C, Acloque H, Genthon C, Donnadieu C, De Vos J, Sanlaville D, Guérin JF, Weber M, Stanton LW, Rougeulle C, Pain B, Bourillot PY, Savatier P.

Nat Commun. 2015 May 13;6:7095. doi: 10.1038/ncomms8095.

11.

Erosion of X Chromosome Inactivation in Human Pluripotent Cells Initiates with XACT Coating and Depends on a Specific Heterochromatin Landscape.

Vallot C, Ouimette JF, Makhlouf M, Féraud O, Pontis J, Côme J, Martinat C, Bennaceur-Griscelli A, Lalande M, Rougeulle C.

Cell Stem Cell. 2015 May 7;16(5):533-46. doi: 10.1016/j.stem.2015.03.016. Epub 2015 Apr 23.

12.

Erratum: A vlincRNA participates in senescence maintenance by relieving H2AZ-mediated repression at the INK4 locus.

Lazorthes S, Vallot C, Briois S, Aguirrebengoa M, Thuret JY, St Laurent G, Rougeulle C, Kapranov P, Mann C, Trouche D, Nicolas E.

Nat Commun. 2015 Apr 8;6:6918. doi: 10.1038/ncomms7918. No abstract available.

13.

A vlincRNA participates in senescence maintenance by relieving H2AZ-mediated repression at the INK4 locus.

Lazorthes S, Vallot C, Briois S, Aguirrebengoa M, Thuret JY, St Laurent G, Rougeulle C, Kapranov P, Mann C, Trouche D, Nicolas E.

Nat Commun. 2015 Jan 20;6:5971. doi: 10.1038/ncomms6971. Erratum in: Nat Commun. 2015;6:6918.

14.

PRC2-independent chromatin compaction and transcriptional repression in cancer.

Vallot C, Hérault A, Boyle S, Bickmore WA, Radvanyi F.

Oncogene. 2015 Feb 5;34(6):741-51. doi: 10.1038/onc.2013.604. Epub 2014 Jan 27.

PMID:
24469045
15.

Long non-coding RNAs and human X-chromosome regulation: a coat for the active X chromosome.

Vallot C, Rougeulle C.

RNA Biol. 2013 Aug;10(8):1262-5. doi: 10.4161/rna.25802. Epub 2013 Jul 19.

16.

[X chromosome inactivation in human: XACT and XIST, a non coding RNA for each X].

Vallot C, Rougeulle C.

Med Sci (Paris). 2013 Feb;29(2):223-5. doi: 10.1051/medsci/2013292024. Epub 2013 Feb 28. Review. French. No abstract available.

17.

XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells.

Vallot C, Huret C, Lesecque Y, Resch A, Oudrhiri N, Bennaceur-Griscelli A, Duret L, Rougeulle C.

Nat Genet. 2013 Mar;45(3):239-41. doi: 10.1038/ng.2530. Epub 2013 Jan 20.

PMID:
23334669
18.

Reducing drinking water supply chemical contamination: risks from underground storage tanks.

Enander RT, Hanumara RC, Kobayashi H, Gagnon RN, Park E, Vallot C, Genovesi R.

Risk Anal. 2012 Dec;32(12):2182-97. doi: 10.1111/j.1539-6924.2012.01843.x. Epub 2012 May 29.

PMID:
22642774
19.

Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.

Tresallet C, Brouquet A, Julié C, Beauchet A, Vallot C, Ménégaux F, Mitry E, Radvanyi F, Malafosse R, Rougier P, Nordlinger B, Laurent-Puig P, Boileau C, Emile JF, Muti C, Penna C, Hofmann-Radvanyi H.

Int J Cancer. 2012 Mar 15;130(6):1367-77. doi: 10.1002/ijc.26144. Epub 2011 Jul 25.

20.

A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression.

Vallot C, Stransky N, Bernard-Pierrot I, Hérault A, Zucman-Rossi J, Chapeaublanc E, Vordos D, Laplanche A, Benhamou S, Lebret T, Southgate J, Allory Y, Radvanyi F.

J Natl Cancer Inst. 2011 Jan 5;103(1):47-60. doi: 10.1093/jnci/djq470. Epub 2010 Dec 20.

21.

Partial reversal of the methylation pattern of the X-linked gene HUMARA during hematopoietic differentiation of human embryonic stem cells.

Mitjavila-Garcia MT, Bonnet ML, Yates F, Haddad R, Oudrhiri N, Féraud O, Magniez A, Makhlouf M, Vallot C, Rougeulle C, Bennaceur-Griscelli A, Turhan AG.

J Mol Cell Biol. 2010 Oct;2(5):291-8. doi: 10.1093/jmcb/mjq026. Epub 2010 Sep 7.

PMID:
20823083
22.

Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer.

Estécio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, Hartung H, Aplan PD, Czerniak BA, Liang S, Issa JP.

Genome Res. 2010 Oct;20(10):1369-82. doi: 10.1101/gr.107318.110. Epub 2010 Aug 17.

23.

A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo.

Fehr T, Lucas CL, Kurtz J, Onoe T, Zhao G, Hogan T, Vallot C, Rao A, Sykes M.

Blood. 2010 Feb 11;115(6):1280-7. doi: 10.1182/blood-2009-07-230680. Epub 2009 Dec 10.

24.

CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.

Kurtz J, Raval F, Vallot C, Der J, Sykes M.

Blood. 2009 Apr 9;113(15):3475-84. doi: 10.1182/blood-2008-01-133736. Epub 2009 Jan 29.

25.

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.

Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frébourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H.

Am J Gastroenterol. 2008 Nov;103(11):2825-35; quiz 2836. doi: 10.1111/j.1572-0241.2008.02084.x. Epub 2008 Aug 27.

PMID:
18759827
26.

Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.

Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, Vallot C, Pierron G, Radvanyi F, Delattre O.

Cancer Res. 2008 Sep 1;68(17):7165-75. doi: 10.1158/0008-5472.CAN-08-1360.

27.

Regional copy number-independent deregulation of transcription in cancer.

Stransky N, Vallot C, Reyal F, Bernard-Pierrot I, de Medina SG, Segraves R, de Rycke Y, Elvin P, Cassidy A, Spraggon C, Graham A, Southgate J, Asselain B, Allory Y, Abbou CC, Albertson DG, Thiery JP, Chopin DK, Pinkel D, Radvanyi F.

Nat Genet. 2006 Dec;38(12):1386-96. Epub 2006 Nov 12. Erratum in: Nat Genet. 2008 Mar;40(3):373.

PMID:
17099711
28.

Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status.

Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M.

Free Radic Biol Med. 1994 Mar;16(3):339-46.

PMID:
8063197
29.

Use of red blood cell indices (MCV, MCH, RDW) in monitoring chronic hemodialysis patients treated with recombinant erythropoietin.

Fialon P, Leaute AG, Sassier P, Vallot C, Wone C.

Pathol Biol (Paris). 1993 Dec;41(10):931-5.

PMID:
8159473
30.

Increase of erythrocyte resistance to hemolysis and modification of membrane lipids induced by hemodialysis.

Peuchant E, Salles C, Vallot C, Wone C, Jensen R.

Clin Chim Acta. 1988 Dec 30;178(3):271-82.

PMID:
3240602
31.

[A case of polycythemia in a patient with chronic renal insufficiency treated by continuous ambulatory peritoneal dialysis].

Ragnaud JM, Vallot C, Woné C.

Presse Med. 1984 Jun 2;13(23):1458-9. French. No abstract available.

PMID:
6233599

Supplemental Content

Loading ...
Support Center